Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Human MATER and Idiopathic Infertility

View source ↗

Summary

The NICHD-sponsored clinical trial evaluating Human MATER in idiopathic infertility has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Infertility | Status: COMPLETED